User profiles for Jianlin Xu
Jianlin (Jim) XuSanofi Verified email at sanofi.com Cited by 1642 |
[HTML][HTML] Development of an intensified fed-batch production platform with doubled titers using N-1 perfusion seed for cell culture manufacturing
The goal of cell culture process intensification is to increase volumetric productivity, generally
by increasing viable cell density (VCD), cell specific productivity or production bioreactor …
by increasing viable cell density (VCD), cell specific productivity or production bioreactor …
Microbial degradation of perchlorate: principles and applications
J Xu, Y Song, B Min, L Steinberg… - Environmental …, 2003 - liebertpub.com
Perchlorate (ClO 4 - ) release into the environment has occurred primarily in association
with its manufacture and use in solid rocket propellant. When released into groundwater, …
with its manufacture and use in solid rocket propellant. When released into groundwater, …
Design and construction of 1D/2D/3D fabric-based wearable micro-supercapacitors
…, X Li, N Yang, X Li, J Yao, W Zhang, R Yan, J Xu… - Journal of Power …, 2023 - Elsevier
Fabric-based micro-supercapacitors have a great potential in the field of wearable flexible
energy storage devices because of the controllable volume, changeable structure, intrinsic …
energy storage devices because of the controllable volume, changeable structure, intrinsic …
New advances in antiangiogenic combination therapeutic strategies for advanced non-small cell lung cancer
H Qiang, Q Chang, J Xu, J Qian, Y Zhang, Y Lei… - Journal of Cancer …, 2020 - Springer
Purpose Tumor growth relies on the sufficient blood supply and continuously requires new
blood vessels to maintain, which lead to vascular abnormalities (Folkman, N Engl J Med 285:…
blood vessels to maintain, which lead to vascular abnormalities (Folkman, N Engl J Med 285:…
Improving titer while maintaining quality of final formulated drug substance via optimization of CHO cell culture conditions in low-iron chemically defined media
During biopharmaceutical process development, it is important to improve titer to reduce
drug manufacturing costs and to deliver comparable quality attributes of therapeutic proteins, …
drug manufacturing costs and to deliver comparable quality attributes of therapeutic proteins, …
Online/at‐line measurement, analysis and control of product titer and critical product quality attributes (CQAs) during process development
…, V Ehamparanathan, Y Song, J Xu… - Biotechnology and …, 2020 - Wiley Online Library
Process analytical technology (PAT) has been defined by the Food and Drug Administration
as a system for designing, analyzing, and controlling manufacturing through timely …
as a system for designing, analyzing, and controlling manufacturing through timely …
Combination of chemotherapy and gefitinib as first‐line treatment for patients with advanced lung adenocarcinoma and sensitive EGFR mutations: a randomized …
B Han, B Jin, T Chu, Y Niu, Y Dong, J Xu… - … journal of cancer, 2017 - Wiley Online Library
To explore the optimal treatment strategy for patients who harbor sensitive EGFR mutations,
a head‐to‐head study was performed to compare chemotherapy and gefitinib in …
a head‐to‐head study was performed to compare chemotherapy and gefitinib in …
Biomanufacturing evolution from conventional to intensified processes for productivity improvement: a case study
Process intensification has shown great potential to increase productivity and reduce costs in
biomanufacturing. This case study describes the evolution of a manufacturing process from …
biomanufacturing. This case study describes the evolution of a manufacturing process from …
EGFR tyrosine kinase inhibitor (TKI) in patients with advanced non-small cell lung cancer (NSCLC) harboring uncommon EGFR mutations: A real-world study in China
J Xu, B Jin, T Chu, X Dong, H Yang, Y Zhang, D Wu… - Lung cancer, 2016 - Elsevier
Introduction There are a number of uncommon EGFR mutations whose associations with
TKIs are not well clarified. Here, we summarize the clinical data of patients with multiple …
TKIs are not well clarified. Here, we summarize the clinical data of patients with multiple …
Brown drug substance color investigation in cell culture manufacturing using chemically defined media: A case study
Drug substance (DS) color is an important quality attribute for release, stability and comparability
studies of biologics. With the increase of DS concentrations and biologics pipelines …
studies of biologics. With the increase of DS concentrations and biologics pipelines …